Albireo to host virtual investor commercial day 2021

Boston, jan. 07, 2021 (globe newswire) -- albireo pharma, inc. (nasdaq: albo), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual commercial day for investors on february 11 from 11:30-1:00pm est.

ALBO Ratings Summary

ALBO Quant Ranking